Fig. 6From: Theranostic RGD@Fe3O4-Au/Gd NPs for the targeted radiotherapy and MR imaging of breast cancerSNR (A) and ∆SNR (B) in MRI images with weight T1 with TE = 12 and TR = 600 ms and different cell groups (from 0 to 550,000 cells) of MCF-7, MCF-10a, SK-BR-3 and MDA-MB-231 cell lines, which were treated with Fe3O4-Au/Gd@RGD and Fe3O4-Au/Gd at a concentration of 0.5 mM and incubation time of 24 hBack to article page